| miRNAs | microRNAs |
| NSCLC | non-small cell lung cancer |
| 3′-UTRs | 3′-untranslated regions |
| SCLC | small cell lung cancer |
| LUAD | lung adenocarcinoma |
| LUSC | lung squamous cell carcinoma |
| pri-miRNAs | primary miRNAs |
| pre-miRNAs | premature miRNAs |
| RNase | ribonuclease |
| RISC | RNA-induced silencing complex |
| PABP | poly(A)-binding protein |
| ceRNAs | competing endogenous RNAs |
| EMT | epithelial-to-mesenchymal transition |
| ECM | extracellular matrix |
| VEGFs | vascular endothelial growth factors |
| MMPs | matrix metalloproteinases |
| MET | mesenchymal-to-epithelial transition |
| tsmiR | tumor suppressive miRNA |
| oncomiR | oncogenic miRNA |
| EGFR | epidermal growth factor receptor |
| ALK | anaplastic lymphoma kinase |
| TNM | tumor, node, metastasis |
| AUROC | area under the receiver operating characteristics |